GlobeNewswire 2023-11-03 MiNK Therapeutics Presents Clinical Activity and Long-Term Persistence of Allogeneic iNKT Cells in S...
GlobeNewswire 2023-10-11 Oxford BioTherapeutics Relocates UK Headquarters to Strategic and Cutting-Edge R&D Location at The O...
GlobeNewswire 2023-09-25 Tecogen Appoints Ms. Susan Hirsch to Board of Directors
GlobeNewswire 2023-08-31 Adagene Reports Six Month Financial Results for 2023 and Provides Corporate Update
GlobeNewswire 2022-03-07 Targovax ASA and Agenus announce collaboration on mutant KRAS cancer vaccine adjuvanted with QS-21 S...
GlobeNewswire 2022-02-22 Sigilon Therapeutics Appoints Sarah Yuan, Ph.D., as Chief Technical Operations Officer
GlobeNewswire 2022-02-22 Oncorus Announces Promotion of John Goldberg, M.D. to Chief Medical Officer
GlobeNewswire 2022-02-15 Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2021 Financial Report
GlobeNewswire 2022-01-26 Polaris to Expand Vacaville Site with Acquisition of 15 Acres
GlobeNewswire 2022-01-05 Agenus to Participate at Upcoming Investor Conferences
GlobeNewswire 2021-12-22 Balstilimab Plus Zalifrelimab Data Published in Journal of Clinical Oncology (JCO)
GlobeNewswire 2021-11-17 Agenus to Participate in 4th Annual Evercore ISI HealthCONx Conference
GlobeNewswire 2021-11-12 Clinical Activity of AGEN1181 Demonstrated Across Nine Treatment-Resistant Cancers at SITC
GlobeNewswire 2021-11-12 MiNK Therapeutics Announces 77% Survival Rate in Intubated Patients with COVID-19 Respiratory Failur...
GlobeNewswire 2021-11-09 Agenus Corporate Update and Third Quarter 2021 Financial Report
GlobeNewswire 2021-11-09 MiNK Therapeutics Presents New Preclinical and Clinical Data on iNKT Cell Therapy Programs at SITC 2...
GlobeNewswire 2021-11-09 Agenus to Participate in Fireside Chat at the B. Riley Fall 2021 Growth Biotech Best Ideas Series
GlobeNewswire 2021-11-04 Agenus to Participate in Webcast Hosted by William Blair to Discuss AGEN1181 Clinical Data from SITC...
GlobeNewswire 2021-10-25 Agenus to Provide Corporate Update and Third Quarter 2021 Financial Report
GlobeNewswire 2021-10-22 Agenus Provides Update on Balstilimab Development
GlobeNewswire 2021-10-12 Agenus to Receive $20M Milestone Payment from Bristol Myers Squibb with Dosing of First Patient with...
GlobeNewswire 2021-10-01 Agenus to Present AGEN1181 Clinical Data at SITC
GlobeNewswire 2021-09-17 Combination of Balstilimab Plus Zalifrelimab Doubles Responses in 2L Cervical Cancer in Data to Be P...
GlobeNewswire 2021-09-15 Saniona appoints Wendy Dwyer as Chief Business Officer
GlobeNewswire 2021-09-10 New Agenus Subsidiary, SaponiQx, Builds Innovative Adjuvant Platform and Forms Collaboration with Gi...